Drug intelligence / Profile preview

allogeneic platelet-rich plasma (soluble platelet factors)

Development stage
Unknown
Lead developer
Republican Research and Practical Center of Transfusion and Medical Biotechnologies
Administration
Topical, Injection
01

Overview

Allogeneic platelet-rich plasma (soluble platelet factors) is a cell-derived therapeutic product developed and manufactured by the Republican Research and Practical Center of Transfusion and Medical Biotechnologies in Belarus. It is composed of a concentrated extract of soluble growth factors and cytokines—such as PDGF, TGF-beta, and VEGF—derived from donor platelets. This formulation is designed to stimulate tissue regeneration, accelerate wound healing, and modulate inflammatory responses by providing essential signaling molecules to the site of injury. Classified as a cell-derived medical device, it has reached approved status in Belarus for clinical applications involving tissue repair and inflammation management.

Other names
Allogeneic PRPSoluble platelet factors
02

Targets

VEGFR (VEGFR family)TGFBR (TGF-beta receptor)FGFR (FGFR family)PDGFR (PDGFR family)EGFR T790M (Epidermal growth factor receptor T790M mutant)

Beyond the preview

Go deeper on allogeneic platelet-rich plasma (soluble platelet factors).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on allogeneic platelet-rich plasma (soluble platelet factors).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call